Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.

Tang JW, Loh TP, Tambyah PA, Koay ES.

Expert Rev Anti Infect Ther. 2012 Jul;10(7):751-60. doi: 10.1586/eri.12.63. Review.

PMID:
22943399
2.

How severe will the flu outbreak be?

Butler D.

Nature. 2009 May 7;459(7243):14-5. doi: 10.1038/459014a. No abstract available.

PMID:
19424121
3.

Update on 2009 pandemic influenza A (H1N1) virus.

Gordon SM.

Cleve Clin J Med. 2009 Oct;76(10):577-82. doi: 10.3949/ccjm.76a.05009. Review.

4.

Seasonal and pandemic influenza: an overview with pediatric focus.

Carr S.

Adv Pediatr. 2012;59(1):75-93. doi: 10.1016/j.yapd.2012.04.016. Review.

PMID:
22789575
5.

Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.

Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, Cui L, Lee CW, Sung WK, Wong CW, Hibberd ML, Kang WL, Seet B, Tambyah PA.

N Engl J Med. 2010 Jun 10;362(23):2166-74. doi: 10.1056/NEJMoa0908482.

6.

Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.

Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS.

Clin Infect Dis. 2010 Apr 1;50(7):963-9. doi: 10.1086/651083.

PMID:
20180701
7.

Influenza in the tropics.

Leo YS, Lye DC, Chow A.

Lancet Infect Dis. 2009 Aug;9(8):457-8. doi: 10.1016/S1473-3099(09)70182-3. No abstract available.

PMID:
19628167
8.

Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects.

Tang JW, Shetty N, Lam TT.

Curr Opin Pulm Med. 2010 May;16(3):235-41. doi: 10.1097/MCP.0b013e3283375727. Review.

PMID:
20375785
9.

Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.

Hall RJ, Peacey MP, Ralston JC, Bocacao J, Ziki M, Gunn W, Quirk A, Huang QS.

Euro Surveill. 2009 Jul 30;14(30):19282.

10.

Experience from influenza A (H1N1) pandemic 2009--is prevention better than cure?

Parikh FS.

J Assoc Physicians India. 2011 Jan;59:11-2. No abstract available.

PMID:
21751658
11.

Influenza A(H1N1)pdm09: beyond the pandemic.

Viasus D, Antón A, Pumarola T, Carratalà J.

Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:54-7. doi: 10.1016/S0213-005X(12)70106-4.

PMID:
23116794
12.

Tamiflu still prudent for pandemic influenza, PHAC maintains.

Eggertson L.

CMAJ. 2010 Feb 9;182(2):E133-4. doi: 10.1503/cmaj.109-3145. Epub 2010 Jan 4. No abstract available.

13.

Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009.

Gutiérrez I, Litzroth A, Hammadi S, Van Oyen H, Gerard C, Robesyn E, Bots J, Faidherbe MT, Wuillaume F.

Euro Surveill. 2009 Aug 6;14(31). pii: 19294. Erratum in: Euro Surveill. 2009;14(32). pii: 19301.

14.

[Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].

Boibieux A.

Ann Fr Anesth Reanim. 2010 Feb;29(2):85-6. doi: 10.1016/j.annfar.2010.01.005. French. No abstract available.

PMID:
20167451
15.

Community transmission of pandemic influenza A (H1N1) in China.

Liu W, Jiang T, Li XF, Tang F, Wei MT, Yu M, Zhao H, Yu XD, Liu LJ, Qin CF, Cao WC.

Infect Control Hosp Epidemiol. 2010 Sep;31(9):961-3. doi: 10.1086/655020.

PMID:
20636129
16.

Preparation for a pandemic: influenza A H1N1.

Shetty P.

Lancet Infect Dis. 2009 Jun;9(6):339-40. No abstract available.

PMID:
19475786
17.

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065. Epub 2012 Dec 26.

18.

Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.

Singh AA.

Natl Med J India. 2009 Mar-Apr;22(2):103. No abstract available.

PMID:
19852352
19.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM; US Antiviral Resistance Surveillance Working Group..

Emerg Infect Dis. 2012 Feb;18(2):308-11. doi: 10.3201/eid1802.111466.

20.

A/H1N1 influenza: questions and answers.

Coombes R.

BMJ. 2009 May 7;338:b1849. doi: 10.1136/bmj.b1849. No abstract available.

PMID:
19423622

Supplemental Content

Support Center